Atlas Trials

Efficacy of metfOrmin in PrevenTIng Glucocorticoid-induced Diabetes in Patients With Brain Metastases

Clinical trial NCT04001725 · UNKNOWN

Trial details

NCT number
NCT04001725
Sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Brain MetastasesMelanomaLung CancerBreast Cancer
Start date
2019-10-15
Primary completion
2021-12-31
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.